The Inhibitory Effect of Interleukin-1beta on Long-term Potentiation is Coupled with Increased Activity of Stress-activated Protein Kinases
Overview
Authors
Affiliations
Long-term potentiation (LTP) in perforant path-granule cell synapses is decreased in aged rats, stressed rats, and rats injected intracerebroventricularly with the proinflammatory cytokine interleukin-1beta (IL-1beta). One factor that is common to these experimental conditions is an increase in the concentration of IL-1beta in the dentate gyrus, suggesting a causal relationship between the compromise in LTP and increased IL-1beta concentration. In this study, we have investigated the downstream consequences of an increase in IL-1beta concentration and report that the reduced LTP in rats injected intracerebroventricularly with IL-1beta was accompanied by a decrease in KCl-stimulated glutamate release in synaptosomes prepared from dentate gyrus, although unstimulated glutamate release was increased. These changes were paralleled by increased activity of the stress-activated kinases, c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase. Intracerebroventricular injection of IL-1beta increased reactive oxygen species production in hippocampal tissue, whereas IL-1beta and H(2)O(2) increased activities of both JNK and p38 in vitro. Dietary manipulation with antioxidant vitamins E and C blocked the increase in reactive oxygen species production, the stimulation of JNK and p38 activity, the attenuation of glutamate release, and the IL-1beta-induced inhibitory of LTP. We propose that IL-1beta stimulates activity of stress-activated kinases, which in turn may inhibit glutamate release and result in compromised LTP and that these actions are a consequence of increased production of reactive oxygen species.
Ozdemir F, Akcay G, Ozkinali S, Celik C Turk J Med Sci. 2024; 53(6):1593-1604.
PMID: 38813490 PMC: 10760556. DOI: 10.55730/1300-0144.5728.
Immunity impacts cognitive deficits across neurological disorders.
Shaw B, Anders V, Tinkey R, Habean M, Brock O, Frostino B J Neurochem. 2023; 168(10):3512-3535.
PMID: 37899543 PMC: 11056485. DOI: 10.1111/jnc.15999.
Aghelan Z, Pashaee S, Abtahi S, Karima S, Khazaie H, Ezati M J Neuroimmune Pharmacol. 2023; 18(3):294-309.
PMID: 37552452 DOI: 10.1007/s11481-023-10078-7.
Olmo B, Bettes M, DeMarsh J, Zhao F, Askwith C, Barrientos R NPJ Sci Food. 2023; 7(1):35.
PMID: 37460765 PMC: 10352252. DOI: 10.1038/s41538-023-00211-4.
Karczewski J, Zielinska A, Staszewski R, Eder P, Dobrowolska A, Souto E Int J Mol Sci. 2022; 23(11).
PMID: 35682824 PMC: 9181303. DOI: 10.3390/ijms23116145.